Hypofractionated Radiotherapy With a Focal Microboost for High-Risk and Locally Advanced Prostate Cancer

Abroad (travel likely)RecruitingPHASE2

Conditions

Prostate Cancer · Prostate Cancer Patients Treated by Radiotherapy

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Medical University of South Carolina Hollings Cancer Center, Charleston, South Carolina, United States
Contact: Study coordinator (Casey Charlton) · charltoc@musc.edu

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Efficacy and Safety of Simultaneous Integrated Boost Radiotherapy in HR/VHR Prostate Cancer With EPLNI

Prostate Cancer Patients Treated by Radiotherapy

Abroad (travel likely)RecruitingPHASE2

Cairo, Egypt · Shibīn al Kawm, Egypt

Assessing Efficacy of Neoadjuvant ADT in Localized High-Risk Prostate Cancer Patients Utilizing 18F-Flotufolastat PSMA PET/CT

Prostate Cancer · Localized Prostate Carcinoma

Abroad (travel likely)RecruitingPHASE2

Miami, United States

Prospective Clinical Trial of 177Lu-P17-088 in the Treatment of Metastatic Castration-Resistant Prostate Cancer

Prostate Cancer

Abroad (travel likely)RecruitingPHASE2

Fuzhou, China

Abi/Pred + ADT vs ADT in PSMA-Positive, Conventionally Node-Negative Prostate Cancer

Prostate Cancer

Abroad (travel likely)RecruitingPHASE2

Omaha, United States